Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
2008 Standout
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
2008
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
2011
Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma
2008
Uniformity in measuring adherence to reporting guidelines: the example of TRIPOD for assessing completeness of reporting of prediction model studies
2019
AHRQ series on complex intervention systematic reviews—paper 6: PRISMA-CI extension statement and checklist
2017
Antidepressants for the treatment of depression in people with cancer
2015
Protocol for CONSORT-SPI: an extension for social and psychological interventions
2013
A manifesto for reproducible science
2017 Standout
La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA
2016 Standout
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2011
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Improving Conduct and Reporting of Narrative Synthesis of Quantitative Data (ICONS-Quant): protocol for a mixed methods study to develop a reporting guideline
2018
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
2020 Standout
The Toxicology of Mercury and Its Chemical Compounds
2006 Standout
Literature survey of high-impact journals revealed reporting weaknesses in abstracts of diagnostic accuracy studies
2015
Reporting quality of diagnostic accuracy studies: a systematic review and meta-analysis of investigations on adherence to STARD
2013
The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines
2018 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
2016 Standout
The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines
2015
Alteration of Matrix Metalloproteinases in Selective Left Ventricular Adriamycin-Induced Cardiomyopathy in the Pig
2009
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa
2012
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
2015 Standout
Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
2017 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Support for reporting guidelines in surgical journals needs improvement: A systematic review
2017
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Developing a reporting guideline for social and psychological intervention trials
2013
The Quality of Reporting of Randomized Controlled Trials of Traditional Chinese Medicine: A Survey of 13 Randomly Selected Journals from Mainland China
2007
Quality of Reporting of Key Methodological Items of Randomized Controlled Trials in Clinical Ophthalmic Journals
2007
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study
2014
Impact of the SCARE guideline on the reporting of surgical case reports: A before and after study
2017
Quality of descriptions of treatments: a review of published randomised controlled trials
2012
Current treatment standards and future strategies in mantle cell lymphoma
2008
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Traditional Chinese medicine
2008 Standout
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
2017 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Recommendations for a uniform assessment of publication bias related to funding source
2013
Reporting of Patient-Reported Outcomes in Randomized Trials
2013
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
2014
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement
2021 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Process evaluation of complex interventions: Medical Research Council guidance
2015 Standout
Reporting Quality of Social and Psychological Intervention Trials: A Systematic Review of Reporting Guidelines and Trial Publications
2013
Quality of reporting of confounding remained suboptimal after the STROBE guideline
2015
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
2020 Standout
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
2015 Standout
The Treatment of Neck Pain–Associated Disorders and Whiplash-Associated Disorders: A Clinical Practice Guideline
2016
Rituximab-Associated Infections
2010
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
2016 Standout
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
The quality of reporting randomized controlled trials in the dermatology literature in an era where the CONSORT statement is a standard
2018
Get the content right: following reporting guidelines will make your research paper more complete, transparent and usable.
2013
Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis
2015
The therapeutic use of rituximab in non‐Hodgkin's lymphoma
2006
Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
2008
What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review
2019 Standout
Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions
2014
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Paroxetine versus other anti-depressive agents for depression
2014
A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma
2008
The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines
2023 Standout
Antidepressants for the treatment of depression in people with cancer
2018
Physiology and toxicology of mercury.
1997
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Industry sponsorship and research outcome
2017 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitro.
1975 StandoutNobel
Works of Thilo Kober being referenced
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals
2012
Fourth Biannual Report of the Cochrane Haematological Malignancies Group
2006
Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis
2007
Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals
2006
Second Biannual Report of the Cochrane Haematological Malignancies Group
2005
Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma
2007
Does Combined Immunochemotherapy with the Monoclonal Antibody Rituximab Improve Overall Survival in the Treatment of Patients with Indolent Non-Hodgkin Lymphoma? Preliminary Results of a Comprehensive Meta-Analysis.
2005